Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN)

Clinical trial NCT04240106 · COMPLETED

Trial details

NCT number: NCT04240106
Sponsor: MedSIR
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Breast Cancer Metastatic

Start date: 2020-06-15
Primary completion: 2022-11-17
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.